6505--ACAMPROSATE CA 333MG EC TAB 180CT - 1 LINE ITEM - 765 HINES

SOL #: 36C77026Q0124Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NATIONAL CMOP OFFICE (36C770)
LEAVENWORTH, KS, 66048, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Timeline

1
Posted
Apr 22, 2026
2
Last Updated
Apr 22, 2026
3
Submission Deadline
Apr 29, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the NATIONAL CMOP OFFICE (36C770), is soliciting proposals for Acamprosate CA 333MG EC TAB 180CT. This is a Total Small Business Set-Aside opportunity under NAICS code 325412 (Pharmaceutical Preparation). Offers are due by April 29, 2026, at 3 PM CDT.

Scope of Work

This solicitation is for the procurement of 1,440 bottles of Acamprosate CA 333MG EC TAB 180CT (NDC: 68462-0435-18). Delivery is FOB Destination within 10 days ARO (After Receipt of Order) to the Great Lakes CMOP in Hines, IL.

Key Requirements:

  • Product: Acamprosate 333MG EC TAB 180CT (NDC: 68462-0435-18).
  • Bar Coding: All pharmaceutical products must include GS1-128 or HIBCC compliant bar code labeling at the unit-of-use package level, encoding the NDC. Bar code quality must meet ANSI/ISO/IEC Grade C or better.
  • Therapeutic Equivalence: Only FDA "A" rated therapeutic equivalents will be considered, unless all drugs in the family group are "B" rated.
  • Expiration Dates: Products must have no less than 12 months expiration from the date of delivery.
  • Packaging: Unit of use packages (below 500 count) require a safety/child-proof cap. Minimum bottle size is 100cc with a cylindrical body and minimum 5.75-inch circumference. Substitutions or partial deliveries require Contracting Officer approval.
  • DSCSA Compliance: Compliance with the Drug Supply Chain Security Act (DSCSA) is required, including submission of Transaction History (TH), Transaction Information (TI), and Transaction Statement (TS).

Contract & Timeline

  • Contract Type: Solicitation (implies a purchase order will result).
  • Set-Aside: Total Small Business Set-Aside (FAR 19.5).
  • NAICS Code: 325412 (Pharmaceutical Preparation) with a size standard of 1300 employees.
  • Response Date: April 29, 2026, 3:00 PM CDT.
  • Published Date: April 22, 2026.

Submission & Evaluation

Required Submission Documents:

  • Signed SF 1449.
  • Completed Pricing Schedule Excel quote spreadsheet.
  • Wholesale distributor license.
  • OEM authorized dealer/distributor documentation (if applicable for OTC products).
  • Completed BAA Certificate (Section E.3).

Evaluation Factors: Delivery, Past Performance, Price, and Technical.

Submission Instructions: All solicitation packages and quotes must be emailed to Jennifer.Coleman4@va.gov. The pricing schedule must be returned in Excel format. Quotes are considered non-compliant if all items are not received.

Additional Notes

Vendors must complete all highlighted areas in the provided pricing spreadsheet. If proposing a different NDC or noting short-dated items, this must be clearly indicated in the "Vendor Comments" section of the spreadsheet.

People

Points of Contact

Jennifer D ColemanContract SpecialistPRIMARY

Files

Files

Download
Download

Versions

Version 2Viewing
Solicitation
Posted: Apr 22, 2026
Version 1
Pre-Solicitation
Posted: Apr 22, 2026
View
6505--ACAMPROSATE CA 333MG EC TAB 180CT - 1 LINE ITEM - 765 HINES | GovScope